Prevalence of anxiety in adults with diabetes: a systematic review (Q34164372)

31 July 2017

1 reference

title

Prevalence of anxiety in adults with diabetes: a systematic review (English)

1 reference

31 July 2017

0 references

1 reference

5

Patrick J Lustman

1 reference

31 July 2017

Allison B Grigsby

1

1 reference

31 July 2017

Ryan J Anderson

series ordinal

2

1 reference

31 July 2017

Kenneth E Freedland

series ordinal

3

1 reference

31 July 2017

Ray E Clouse

series ordinal

4

1 reference

31 July 2017

language of work or name

1 reference

1 December 2002

1 reference

Journal of Psychosomatic Research

31 July 2017

1 reference

31 July 2017

53

1 reference

31 July 2017

6

1 reference

31 July 2017

1053-1060

1 reference

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Phobic symptoms, particularly the fear of blood and injury, are associated with poor glycemic control in type I diabetic adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Effects and correlates of blood glucose awareness training among patients with IDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Psychosocial sequelae of visual loss in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Consequences of anxiety in older persons: its effect on disability, well-being and use of health services.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Estimates of use and costs of behavioural health care: a comparison of standard and finite mixture models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

A diagnostic interview: the schedule for affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Epidemiology of anxiety disorders in Florence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Untreated anxiety among adult primary care patients in a Health Maintenance Organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Anxiety and depressive disorders in an adult insulin-dependent diabetic mellitus (IDDM) population: relationships with glycaemic control and somatic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

The treatment of emotional disorders in general practice: psychological methods versus medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Post-traumatic stress disorder in the general population. Findings of the epidemiologic catchment area survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Utilization of medical specialists by anxiety disorder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Effects of both the emotional behavior and feeding conditions on the circulating plasma volume and plasma glucose levels in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Relaxation training for NIDDM. Predicting who may benefit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Stress and immune function in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Prevalence of symptoms of depression and anxiety in a diabetes clinic population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Anxiety disorders in adults with diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Stress and diabetic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Relationship of psychiatric illness to impotence in men with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Effects of alprazolam on glucose regulation in diabetes. Results of double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Effects of insulin and streptozotocin-induced diabetes on brain tryptophan and serotonin metabolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Role of mood in outcome of biofeedback assisted relaxation therapy in insulin dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Quality of life in individuals with anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Treatment typically provided for comorbid anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Psychosocial correlates of hemoglobin Alc in young adults with type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Effect of an anxiolytic on lipid profile in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Recognition, management, and course of anxiety and depression in general practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Levels and risks of depression and anxiety symptomatology among diabetic adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Personality profile and affective state of patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Psychological issues and treatments for people with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Utilization of health and mental health services. Three Epidemiologic Catchment Area sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Animal models provide insight into psychosomatic factors in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Differences between bulimia nervosa and binge-eating disorder in females with type 1 diabetes: the important role of insulin omission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Effects of insulin and streptozotocin-induced diabetes on brain norepinephrine metabolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Glycosylated hemoglobin levels in anxious and nonanxious diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Psychiatric morbidity and social problems in patients with insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

The hospital anxiety and depression scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

A Rating Instrument For Anxiety Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Epidemiology of trauma: frequency and impact of different potentially traumatic events on different demographic groups

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900417-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3999(02)00417-8

1 reference

31 July 2017

1 reference